人工智能影像分析助力实体型肺腺癌定义:提升临床相关性
本研究纳入216例cN0肺腺癌(病理浸润直径≤30mm)行肺叶切除加淋巴结清扫的患者,用AI软件计算实性成分体积比(cV/tV)并与放射科医生定义的实性成分直径比(cD/tD)比较。结果显示cV/tV≥0.72的阈值能准确预测淋巴结转移,在≤20mm肿瘤中该阈值以下无淋巴结转移且5年无复发生存率100%。
要点
- AI计算cV/tV≥0.72可客观定义实体型肿瘤并预测淋巴结转移
- cV/tV≥0.72较传统cD/tD=1.0维持相似病理浸润比但一致性更优
- ≤20mm且cV/tV<0.72的肿瘤无淋巴结转移,5年RFS为100%
核心结论
- 基于AI的体积分析cV/tV≥0.72在单中心回顾性研究中可预测≤30mm肺腺癌的淋巴结转移,但临床实施前需多中心外部验证。
研究设计与样本
- 单中心回顾性研究,纳入216例cN0肺腺癌(病理浸润直径≤30mm)行肺叶切除加淋巴结清扫的患者。
主要发现
- cV/tV≥0.72的阈值能准确预测淋巴结转移并提升AI与放射科医生评估实体肿瘤的一致性。
- 在≤20mm肿瘤中,cV/tV<0.72组未见淋巴结转移,5年无复发生存率为100%。
关键数值与推荐
- cV/tV≥0.72作为预测淋巴结转移的阈值。
- cV/tV≥0.72时病理浸润直径/肿瘤直径比与传统cD/tD=1.0阈值相似。
临床怎么用
- AI体积分析cV/tV≥0.72可辅助客观定义实体型肺腺癌,帮助筛选≤20mm且低实性成分患者行有限切除。
局限性
- 单中心回顾性研究,临床实施前需多中心外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Non-small-cell lung cancer (NSCLC) lesions appearing solid on imaging are highly likely to be malignant. However, "solid" has a subjective definition. This study aimed to determine whether artificial intelligence (AI)-based imaging analysis can offer a more objective and clinically meaningful definition of solid tumours, specifically in regards to lymph node metastasis and prognosis. METHODS: This study included 216 patients with cN0 lung adenocarcinoma (pathological invasive diameter ≤ 30 mm) who underwent lobectomy with lymph node dissection. AI software was used to calculate the consolidation-to-tumour diameter (cD/tD) and volume (cV/tV) ratios, which were then compared with radiologist-defined cD/tD. To determine the optimal cutoff values, correlations between the pathological invasive diameter/tumour diameter ratio (PathoiD/tD) and lymph node metastasis were evaluated. Subsequently, these values were applied to a subset of tumours measuring ≤20 mm (n = 117) to determine their potential use in candidate selection for limited resection. RESULTS: A cV/tV cutoff value of ≥0.72 accurately predicted lymph node metastasis and improved concordance between AI and radiologist solid tumour assessment while maintaining a similar PathoiD/tD to the conventional (cD/tD = 1.0) threshold. Among tumours measuring ≤20 mm in the low solid-component group (cV/tV <0.72), lymph node metastases were not observed; the 5-year recurrence-free survival rate was 100%. CONCLUSIONS: An AI-based volumetric analysis using a cV/tV threshold of ≥0.72 showed potential for predicting lymph node metastasis in this single-centre retrospective study of lung adenocarcinoma ≤30 mm. External validation in diverse, multicentre cohorts is essential before clinical implementation.
引用
- Nishida T, Yanagawa M, Sato J, et al. Artificial Intelligence-Advanced Imaging for Solid-Type Lung Adenocarcinoma: Towards Greater Clinical Relevance. Eur J Cardiothorac Surg. 2025. PMID: 41212778. doi:10.1093/ejcts/ezaf385
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。